49 related articles for article (PubMed ID: 38279449)
1. High CASC expression predicts poor prognosis of lung cancer: A systematic review with meta-analysis.
Han H; Huang H; Chen AP; Tang Y; Huang X; Chen C
PLoS One; 2024; 19(4):e0292726. PubMed ID: 38573879
[TBL] [Abstract][Full Text] [Related]
2. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
3. An increase in SNHG5 expression is associated with poor cancer prognosis, according to a meta-analysis.
Huang Q; Xia YG; Huang YJ; Qin HF; Zhang QX; Wei CF; Tang WR; Liao Y
Eur J Med Res; 2024 Mar; 29(1):160. PubMed ID: 38475928
[TBL] [Abstract][Full Text] [Related]
4. Survival and clinicopathological significance of B7-H3 in bladder cancer: a systematic review and meta-analysis.
Sun H; Gao F; Liu Y; Shao J
BMC Urol; 2024 Mar; 24(1):57. PubMed ID: 38468228
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of LncRNA BLACAT1 overexpression in various tumors: a meta-analysis.
Yan X; Zhang N; Wang G; Wang J
Front Genet; 2024; 15():1362420. PubMed ID: 38601076
[TBL] [Abstract][Full Text] [Related]
6. High expression of ANRIL correlated with the poor prognosis in patients with cancer: A meta-analysis.
Liu Y; Zhu L; Zhao W; Zhou Y; Shao S
Medicine (Baltimore); 2022 Sep; 101(36):e30531. PubMed ID: 36086708
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of lncRNA AL354919.2 in bladder cancer.
Mao Q; Liu H; Wu J; Cui Y
Asian J Surg; 2024 May; 47(5):2410-2412. PubMed ID: 38278734
[No Abstract] [Full Text] [Related]
8. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.
Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W
Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523
[TBL] [Abstract][Full Text] [Related]
10. The relationship between the expression of lncRNA MALAT1 and clinical features and prognosis in bladder cancer: A meta-analysis.
Su Y; Chen H; Yao L; Dai H; Liu H
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):166-171. PubMed ID: 38279449
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.
Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102
[No Abstract] [Full Text] [Related]
12. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA TUG1 as a Potential Novel Biomarker for Predicting the Clinical Outcome of Cancer Patients: a Meta-Analysis.
Li B; Shen S; Zhang W; Qi T; Hu Q; Cheng Y
Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549987
[No Abstract] [Full Text] [Related]
14. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer.
Li C; Cui Y; Liu LF; Ren WB; Li QQ; Zhou X; Li YL; Li Y; Bai XY; Zu XB
Clin Genitourin Cancer; 2017 Oct; 15(5):570-576. PubMed ID: 28648755
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
